A national strategy for vaccine distribution is essential to ensure transparency and consistency, preventing public distrust. The discussion highlights the importance of prioritizing high-risk groups and the implications of vaccine nationalism, particularly in the context of the U.S. decision not to participate in COVAX. Effective allocation should focus on hotspots to control infection and prevent widespread outbreaks.
